On May 21, JD.com (09618.HK) fell 3.13% in regular trading, trading at 123.5 HKD/share, with trading volume of 513 million HKD.

The decline came amid a broad sell-off in Hong Kong-listed technology stocks. Market reports indicated that renowned investor Duan Yongping, through H&H International Investment, filed a Q1 13F report with the US SEC revealing a complete exit of his Alibaba position, dampening sentiment across the Chinese internet sector. Bilibili fell over 6%, Baidu dropped more than 3%, while Kuaishou and Alibaba declined over 2%.

Within the Internet and Direct Marketing Retail sector, stocks were broadly under pressure. Among peers, Alibaba fell 3.87%, Meituan edged up 0.06%, JD Health declined 0.69%, Ali Health dropped 0.77%, and Ping An Good Doctor fell 2.50%. Notably, Nomura had recently raised JD.com's target price to $41 from $40 on May 15, maintaining a Buy rating after Q1 results beat expectations, highlighting improved profitability and narrowing losses in its live-commerce business.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)